Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
Titel:
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
Auteur:
Lee, Jong Wook Griffin, Morag Kim, Jin Seok Lee Lee, Lily Wong Piatek, Caroline Nishimura, Jun-ichi Carrillo Infante, Cynthia Jain, Deepak Liu, Peng Filippov, Gleb Sicre de Fontbrune, Flore Risitano, Antonio Kulasekararaj, Austin G